Literature DB >> 36245668

Vancomycin Should Be Considered a Nephrotoxic Antimicrobial Agent: PRO.

Mark E Murphy1,2,3, Erin F Barreto4.   

Abstract

Entities:  

Keywords:  acute kidney injury; acute kidney injury and ICU nephrology; adverse drug reaction; antibiotic; pharmacokinetic/pharmacodynamics; renal failure; toxicity; vancomycin

Mesh：

Substances：

Year:  2022        PMID： 36245668      PMCID： PMC9528380          DOI： 10.34067/KID.0008032021

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  10 in total

1.  Vancomycin-Associated Cast Nephropathy.

Authors:  Yosu Luque; Kevin Louis; Chantal Jouanneau; Sandrine Placier; Emmanuel Esteve; Dominique Bazin; Eric Rondeau; Emmanuel Letavernier; Alice Wolfromm; Clément Gosset; Anna Boueilh; Maren Burbach; Perrine Frère; Marie-Christine Verpont; Sophie Vandermeersch; Dominique Langui; Michel Daudon; Vincent Frochot; Laurent Mesnard
Journal:  J Am Soc Nephrol       Date:  2017-01-12       Impact factor: 10.121

2.  The relationship between serum neutrophil gelatinase-associated lipocalin and renal function in patients with vancomycin treatment.

Authors:  Hyung-Doo Park; Ja-Young Seo; Soo-Youn Lee
Journal:  Ann Clin Lab Sci       Date:  2012       Impact factor: 1.256

3.  Prospective Trial on the Use of Trough Concentration versus Area under the Curve To Determine Therapeutic Vancomycin Dosing.

Authors:  Michael N Neely; Lauren Kato; Gilmer Youn; Lironn Kraler; David Bayard; Michael van Guilder; Alan Schumitzky; Walter Yamada; Brenda Jones; Emi Minejima
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

4.  Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.

Authors:  Richard G Wunderink; Michael S Niederman; Marin H Kollef; Andrew F Shorr; Mark J Kunkel; Alice Baruch; William T McGee; Arlene Reisman; Jean Chastre
Journal:  Clin Infect Dis       Date:  2012-01-12       Impact factor: 9.079

Review 5.  Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials.

Authors:  Liang Beibei; Cai Yun; Chen Mengli; Bai Nan; Yu Xuhong; Wang Rui
Journal:  Int J Antimicrob Agents       Date:  2009-11-08       Impact factor: 5.283

6.  Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

Authors:  Michael J Rybak; Jennifer Le; Thomas P Lodise; Donald P Levine; John S Bradley; Catherine Liu; Bruce A Mueller; Manjunath P Pai; Annie Wong-Beringer; John C Rotschafer; Keith A Rodvold; Holly D Maples; Benjamin Lomaestro
Journal:  Clin Infect Dis       Date:  2020-09-12       Impact factor: 9.079

Review 7.  Vancomycin-Induced Kidney Injury: Animal Models of Toxicodynamics, Mechanisms of Injury, Human Translation, and Potential Strategies for Prevention.

Authors:  Gwendolyn M Pais; Jiajun Liu; Sanja Zepcan; Sean N Avedissian; Nathaniel J Rhodes; Kevin J Downes; Ganesh S Moorthy; Marc H Scheetz
Journal:  Pharmacotherapy       Date:  2020-05-04       Impact factor: 4.705

8.  The Emperor's New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE).

Authors:  Thomas P Lodise; Susan L Rosenkranz; Matthew Finnemeyer; Scott Evans; Matthew Sims; Marcus J Zervos; C Buddy Creech; Pratish C Patel; Michael Keefer; Paul Riska; Fernanda P Silveira; Marc Scheetz; Richard G Wunderink; Martin Rodriguez; John Schrank; Susan C Bleasdale; Sara Schultz; Michelle Barron; Ann Stapleton; Dannah Wray; Henry Chambers; Vance G Fowler; Thomas L Holland
Journal:  Clin Infect Dis       Date:  2020-04-10       Impact factor: 9.079

9.  Phenotype standardization for drug-induced kidney disease.

Authors:  Ravindra L Mehta; Linda Awdishu; Andrew Davenport; Patrick T Murray; Etienne Macedo; Jorge Cerda; Raj Chakaravarthi; Arthur L Holden; Stuart L Goldstein
Journal:  Kidney Int       Date:  2015-04-08       Impact factor: 10.612

Review 10.  The Whole Price of Vancomycin: Toxicities, Troughs, and Time.

Authors:  Meghan N Jeffres
Journal:  Drugs       Date:  2017-07       Impact factor: 9.546
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.